[{"quiz_id": "ABMS20260101_deepseek-v3.2_p05", "question_id": "ABMS20260101_deepseek-v3.2_p05-001", "question": "A 44-year-old woman with autoimmune hepatitis-primary biliary cholangitis overlap syndrome on ursodeoxycholic acid and budesonide develops recurrent episodes of severe, cramping abdominal pain with diarrhea occurring 30-60 minutes after meals. Symptoms improve with fasting. CT angiography shows no mesenteric ischemia. Gastric emptying study is normal. Upper endoscopy with duodenal biopsies shows villous blunting and intraepithelial lymphocytes. Serum tryptase during an episode is 45 ng/mL (normal <11.4). Which of the following is the most likely diagnosis?", "options": ["Mesenteric venous thrombosis with portal hypertensive enteropathy", "Systemic mastocytosis with gastrointestinal involvement", "Celiac disease with refractory sprue", "Abdominal angina from median arcuate ligament syndrome", "Bile acid malabsorption due to ileal dysfunction"], "answer": "B", "answer_index": 1, "explanation": "Systemic mastocytosis can present with postprandial abdominal pain, diarrhea, and flushing due to mast cell mediator release triggered by food. Elevated serum tryptase (>20 ng/mL) during symptoms is diagnostic. The duodenal findings represent mast cell infiltration rather than celiac disease. Mesenteric ischemia was ruled out by CT angiography. Median arcuate ligament syndrome causes epigastric pain but not diarrhea or elevated tryptase. Bile acid malabsorption does not explain the elevated tryptase or timing of symptoms.", "generator_model": "deepseek-v3.2", "seed": 133, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Gastrointestinal", "abms_specialty": "Gastrointestinal", "abms_source": "target_topic", "source_label_raw": "Gastrointestinal", "source_quiz_id": "20251219T221819110Z_deepseek-v3.2_seed133", "source_question_id": "20251219T221819110Z_deepseek-v3.2_seed133-004", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/deepseek-v3.2/20251219T221819110Z_deepseek-v3.2_seed133", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251219T221819110Z_deepseek-v3.2_seed133.jsonl", "pred": "B", "model_outputs": "This patient presents with postprandial abdominal pain, diarrhea, duodenal villous atrophy with intraepithelial lymphocytes, and a significantly elevated serum tryptase level (45 ng/mL).\n\n1.  Elevated Tryptase: A baseline serum tryptase level greater than 20 ng/mL is a minor diagnostic criterion for Systemic Mastocytosis (SM). A level of 45 ng/mL is highly suggestive of a significant mast cell burden.\n2.  GI Involvement: Gastrointestinal symptoms are very common in systemic mastocytosis (seen in ~80% of patients). Symptoms include abdominal pain, diarrhea, nausea, and vomiting, often triggered by meals (due to mast cell degranulation).\n3.  Histology: While duodenal villous blunting and increased intraepithelial lymphocytes are the hallmark of celiac disease, identical findings can be observed in gastrointestinal mastocytosis. Because the patient has autoimmune liver disease, celiac disease is a reasonable consideration, but celiac disease does not cause a serum tryptase elevation to this degree.\n4.  Negative Workup for Ischemia: The CT angiography ruled out mesenteric ischemia (and MALS), and the nature of the symptoms combined with the biomarker points away from structural vascular causes.\n\nTherefore, the combination of clinical symptoms, histologic findings mimicking celiac disease, and the elevated tryptase level makes systemic mastocytosis the most likely diagnosis.\n\nThe answer is (B)"}, {"quiz_id": "ABMS20260101_deepseek-v3.2_p05", "question_id": "ABMS20260101_deepseek-v3.2_p05-002", "question": "A 29-year-old woman presents with 6 months of progressive dyspnea and palpitations. Echocardiogram shows severe pulmonary hypertension (RVSP 85 mmHg) with right ventricular dilation but normal left heart function. Right heart catheterization confirms pre-capillary pulmonary hypertension (mPAP 48 mmHg, PAWP 10 mmHg). High-resolution CT shows mosaic attenuation and enlarged central pulmonary arteries. Ventilation-perfusion scan reveals multiple segmental perfusion defects. Which of the following is the definitive diagnostic test?", "options": ["Pulmonary angiogram", "CT pulmonary angiogram", "Genetic testing for BMPR2 mutation", "Lung biopsy", "Exercise right heart catheterization"], "answer": "A", "answer_index": 0, "explanation": "This presentation is classic for chronic thromboembolic pulmonary hypertension (CTEPH). While V/Q scan is the screening test, pulmonary angiography remains the gold standard for defining surgical accessibility and planning pulmonary endarterectomy. CT pulmonary angiography (B) provides anatomical detail but has lower sensitivity for chronic thromboembolic material. Genetic testing (C) is for heritable pulmonary arterial hypertension, not CTEPH. Lung biopsy (D) is contraindicated in severe pulmonary hypertension. Exercise catheterization (E) may confirm exercise-induced PH but doesn't diagnose CTEPH. Pulmonary angiography is essential for determining operability in CTEPH.", "generator_model": "deepseek-v3.2", "seed": 124, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Pulmonary", "abms_specialty": "Pulmonary", "abms_source": "topics_mapped", "source_label_raw": "pulmonology", "source_quiz_id": "20251205T082731900Z_deepseek-v3.2_seed124", "source_question_id": "20251205T082731900Z_deepseek-v3.2_seed124-006", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/deepseek-v3.2/20251205T082731900Z_deepseek-v3.2_seed124", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251205T082731900Z_deepseek-v3.2_seed124.jsonl", "pred": null, "model_outputs": "Batch error (1): The operation was cancelled."}, {"quiz_id": "ABMS20260101_deepseek-v3.2_p05", "question_id": "ABMS20260101_deepseek-v3.2_p05-003", "question": "A 67-year-old man who underwent orthotopic liver transplantation 4 months ago for HCV cirrhosis presents with fever, cough, and hypoxemia. He is on tacrolimus and prednisone 5 mg daily. Chest CT shows multiple nodular opacities with surrounding ground-glass halos. Bronchoalveolar lavage PCR is positive for Torque teno virus (TTV) DNA at 10^8 copies/mL. Blood TTV viral load is 10^7 copies/mL. Which of the following is the most appropriate interpretation and management?", "options": ["TTV indicates severe immunosuppression; reduce tacrolimus dose and monitor for resolution", "TTV is a direct pulmonary pathogen; initiate intravenous ribavirin therapy", "TTV reactivation suggests CMV co-infection; start ganciclovir empirically", "TTV viral load has no clinical significance in this setting; pursue alternative diagnoses", "TTV indicates possible donor-derived infection; perform lung biopsy for histopathology"], "answer": "A", "answer_index": 0, "explanation": "Torque teno virus (TTV) viral load serves as a functional biomarker of overall immunosuppression in transplant recipients, with high levels indicating excessive immunosuppression and increased risk of opportunistic infections. The radiographic findings suggest invasive fungal infection (e.g., aspergillosis) in an over-immunosuppressed host. Reducing immunosuppression while evaluating for fungal pathogens is appropriate. TTV itself is not a pulmonary pathogen. There is no established antiviral therapy for TTV, and it does not specifically indicate CMV co-infection or donor-derived infection.", "generator_model": "deepseek-v3.2", "seed": 133, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Infectious Disease", "abms_specialty": "Infectious Disease", "abms_source": "target_topic", "source_label_raw": "Infectious Disease", "source_quiz_id": "20251219T221819110Z_deepseek-v3.2_seed133", "source_question_id": "20251219T221819110Z_deepseek-v3.2_seed133-003", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/deepseek-v3.2/20251219T221819110Z_deepseek-v3.2_seed133", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251219T221819110Z_deepseek-v3.2_seed133.jsonl", "pred": "D", "model_outputs": "This question tests the understanding of the clinical significance of Torque teno virus (TTV) in solid organ transplant (SOT) recipients and the differential diagnosis of pulmonary opacities in this population.\n\n1.  Clinical Picture: The patient is an immunosuppressed liver transplant recipient presenting with fever, cough, and \"nodular opacities with surrounding ground-glass halos\" (the halo sign). The halo sign is a classic radiographic finding of hemorrhagic infarction surrounding a nodule, highly suggestive of Invasive Pulmonary Aspergillosis (IPA) or other angioinvasive fungal infections (like Mucormycosis) in this patient population.\n\n2.  Torque teno virus (TTV): TTV is a small, non-enveloped, single-stranded DNA virus (Anelloviridae). It is ubiquitous in the general population, establishing chronic, asymptomatic viremia in nearly all adults.\n    *   Pathogenicity: TTV is currently considered non-pathogenic. No definitive causal link to specific diseases (hepatitis, pneumonia, etc.) has been established.\n    *   Biomarker Utility: In SOT, TTV viral load is inversely correlated with the competence of the immune system. High TTV loads reflect strong immunosuppression (predicting a higher risk of opportunistic infection), while low loads indicate robust immune function (predicting a risk of rejection).\n\n3.  Evaluating the Options:\n    *   A: While high TTV loads do suggest significant immunosuppression, the management strategy is flawed. The patient has a potentially life-threatening infection (suspected IPA). Simply reducing tacrolimus and \"monitoring for resolution\" is inappropriate; active targeted antifungal therapy and diagnostic confirmation are required.\n    *   B: TTV is not considered an etiologic agent of pneumonia, nor is there evidence to treat it with ribavirin.\n    *   C: TTV reactivation does not specifically predict CMV co-infection in a way that justifies empirical ganciclovir without a positive CMV test.\n    *   D: This is the correct interpretation. In the context of investigating the etiology of the pulmonary nodules, the detection of TTV is an incidental finding or a marker of the host's immune status, not the cause of the disease. The presence of TTV DNA is expected in immunosuppressed patients. The clinician must not attribute the symptoms to TTV but must vigorously pursue the actual diagnosis (likely fungal) via biopsy or galactomannan testing.\n    *   E: While a biopsy might be indicated to diagnose the nodules, the reasoning that TTV indicates a specific \"donor-derived infection\" causing the pathology is incorrect. TTV does not cause the nodules.\n\nTherefore, the detection of TTV should not distract from the workup of the serious pulmonary pathology.\n\nThe answer is (D)"}, {"quiz_id": "ABMS20260101_deepseek-v3.2_p05", "question_id": "ABMS20260101_deepseek-v3.2_p05-004", "question": "A 4-year-old boy with DiGeorge syndrome (22q11.2 deletion) develops pneumonia requiring hospitalization. He has previously undergone complete repair of tetralogy of Fallot and receives supplemental calcium and vitamin D for hypoparathyroidism. During hospitalization, he develops refractory hypocalcemia (ionized calcium 0.8 mmol/L) despite IV calcium gluconate. ECG shows prolonged QTc interval. Parathyroid hormone is undetectable. Which of the following electrolyte abnormalities most likely explains the calcium refractory to therapy?", "options": ["Hypomagnesemia (0.9 mg/dL)", "Hyperphosphatemia (8.2 mg/dL)", "Metabolic alkalosis (pH 7.48)", "Hyperkalemia (6.2 mEq/L)", "Hyponatremia (125 mEq/L)"], "answer": "A", "answer_index": 0, "explanation": "In DiGeorge syndrome with hypoparathyroidism, refractory hypocalcemia is most commonly due to hypomagnesemia, as magnesium is required for PTH secretion and end-organ response. Magnesium deficiency impairs both PTH release (already absent here) and the ability of administered PTH/calcium to maintain calcium levels. Hyperphosphatemia can lower calcium but doesn't cause refractoriness to IV calcium. Alkalosis increases protein binding but not true refractoriness. Hyperkalemia and hyponatremia don't directly affect calcium responsiveness. Magnesium repletion must precede effective calcium management in this setting.", "generator_model": "deepseek-v3.2", "seed": 132, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Pediatrics", "abms_specialty": "Pediatrics", "abms_source": "target_topic", "source_label_raw": "Pediatrics", "source_quiz_id": "20251219T221819110Z_deepseek-v3.2_seed132", "source_question_id": "20251219T221819110Z_deepseek-v3.2_seed132-012", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/deepseek-v3.2/20251219T221819110Z_deepseek-v3.2_seed132", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251219T221819110Z_deepseek-v3.2_seed132.jsonl", "pred": "A", "model_outputs": "This question describes a patient with DiGeorge syndrome (which causes congenital hypoparathyroidism) presenting with pneumonia and refractory hypocalcemia.\n\n1.  Patient's Baseline: The patient has DiGeorge syndrome and typically has hypocalcemia due to hypoplastic or aplastic parathyroid glands (low/absent PTH). He is treated with calcium and vitamin D.\n2.  Current Problem: He has severe hypocalcemia (ionized calcium 0.8 mmol/L) that is refractory to IV calcium gluconate administration.\n3.  Mechanism of Refractory Hypocalcemia: The most common cause of hypocalcemia that fails to respond to calcium replacement therapy is hypomagnesemia.\n    *   Magnesium is crucial for calcium homeostasis. Interrelationship mechanisms include:\n        *   Impaired PTH Secretion: Magnesium is required for the release of PTH. (Note: In this specific patient, PTH is already undetectable due to his syndrome, so this mechanism is less relevant).\n        *   End-Organ Resistance: Severe hypomagnesemia causes end-organ resistance to PTH at the level of the bone and kidney. Even if the patient is receiving Vitamin D / Calcium, or has trace PTH, low magnesium alters the function of the calcium-sensing receptors and adenylate cyclase systems, preventing the mobilization of calcium and renal conservation.\n        *   Vitamin D Resistance: Hypomagnesemia can also impair the activation of Vitamin D and peripheral responsiveness to it.\n4.  Evaluating the Data:\n    *   Option A (Hypomagnesemia 0.9 mg/dL): Normal magnesium levels are typically 1.7–2.2 mg/dL. A level of 0.9 mg/dL represents severe hypomagnesemia. This is the classic cause of \"refractory hypocalcemia.\" Calcium levels will not correct until the magnesium deficit is repleted.\n    *   Option B (Hyperphosphatemia 8.2 mg/dL): While hyperphosphatemia is common in hypoparathyroidism (due to lack of phosphaturic effect of PTH) and can lower calcium via precipitation, the specific clinical picture of *refractoriness* to parenteral calcium is strongly associated with magnesium depletion. Additionally, while 8.2 mg/dL is high, children have higher baseline phosphate thresholds than adults.\n    *   Option C (Metabolic Alkalosis): Alkalosis increases the binding of calcium to albumin, lowering *ionized* calcium. While the pH is 7.48, acute IV calcium administration should still raise the measurable ionized calcium transiently; it does not typically cause total lack of response (refractoriness) to high-dose IV therapy in the same way hypomagnesemia does.\n    *   Options D & E: Hyperkalemia and hyponatremia do not directly cause refractory hypocalcemia.\n\nTherefore, the presence of severe hypomagnesemia prevents the correction of hypocalcemia. The magnesium must be corrected to restore calcium homeostasis.\n\nThe answer is (A)"}, {"quiz_id": "ABMS20260101_deepseek-v3.2_p05", "question_id": "ABMS20260101_deepseek-v3.2_p05-005", "question": "A 28-year-old male presents to the ED with 2 hours of severe, tearing interscapular back pain radiating to the left flank. He has a history of Marfan syndrome. Vital signs: BP 180/110 mmHg in right arm, 100/60 mmHg in left arm, HR 120 bpm, SpO2 98% on room air. ECG shows sinus tachycardia. Portable CXR shows a widened mediastinum. Bedside transthoracic echocardiogram shows normal left ventricular function, no pericardial effusion, and a normal aortic root at the level of the sinuses of Valsalva. What is the most appropriate immediate management step?", "options": ["A. Administer IV labetalol to target systolic BP <120 mmHg", "B. Obtain an emergent CT angiogram of the chest/abdomen/pelvis", "C. Start an IV esmolol infusion to target heart rate <60 bpm and systolic BP <120 mmHg", "D. Administer IV morphine for pain control and arrange transfer to the operating room", "E. Perform transesophageal echocardiography in the ED to better visualize the aortic arch"], "answer": "C", "answer_index": 2, "explanation": "In acute aortic dissection (strongly suggested by pain, pulse deficit, and mediastinal widening), the priority is to reduce shear stress via heart rate and blood pressure control before definitive imaging. Esmolol is the preferred agent as it is a short-acting beta-blocker; pure vasodilators like nitroprusside can increase shear stress if used without beta-blockade. While CT angiography (B) is the definitive diagnostic test, controlling hemodynamics first minimizes the risk of extension or rupture during the scan. Labetalol (A) is appropriate but the specified target is too aggressive initially; a systolic BP of 100-120 mmHg is the goal. Direct transfer (D) or TEE (E) without hemodynamic control is dangerous.", "generator_model": "deepseek-v3.2", "seed": 134, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Emergency Medicine", "abms_specialty": "Emergency Medicine", "abms_source": "target_topic", "source_label_raw": "Emergency Medicine", "source_quiz_id": "20251225T200227925Z_deepseek-v3.2_seed134", "source_question_id": "20251225T200227925Z_deepseek-v3.2_seed134-001", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/deepseek-v3.2/20251225T200227925Z_deepseek-v3.2_seed134", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251225T200227925Z_deepseek-v3.2_seed134.jsonl", "pred": "C", "model_outputs": "This patient presents with signs and symptoms highly suggestive of acute aortic dissection (AAD): tearing interscapular pain, history of Marfan syndrome, hypertension, widened mediastinum on CXR, and a pulse differential between the upper extremities (suggesting involvement of the left subclavian artery).\n\nThe immediate clinical priority in a stable (or hypertensive) patient with suspected aortic dissection is \"anti-impulse therapy\" to reduce the shear stress ($dP/dt$) on the aortic wall, which minimizes the risk of dissection propagation or rupture.\n\nManagement priorities:\n1.  Heart Rate Control: The primary goal is to reduce the heart rate to <60 bpm. This reduces the frequency of the ejection force and the force of contraction. Beta-blockers are the first-line agents.\n2.  Blood Pressure Control: After (or simultaneous with) heart rate control, the systolic blood pressure should be lowered to 100–120 mmHg.\n3.  Diagnosis: Once hemodynamic stabilization has been initiated, definitive imaging (CT angiography) is performed.\n\nEvaluating the Options:\n*   A. Administer IV labetalol to target systolic BP <120 mmHg: Labetalol is an appropriate drug (combined alpha/beta-blocker). However, this option only lists the blood pressure target. Reducing BP without ensuring strict rate control is insufficient, as shear stress depends heavily on heart rate and contractility.\n*   B. Obtain an emergent CT angiogram: While CT is the diagnostic gold standard, sending a patient with a heart rate of 120 bpm and SBP of 180 mmHg to the scanner without medical stabilization poses a high risk of rupture. Medical management should be started immediately/concurrently.\n*   C. Start an IV esmolol infusion to target heart rate <60 bpm and systolic BP <120 mmHg: This option correctly identifies the drug class (beta-blocker) and, most importantly, explicitly states the standard hemodynamic targets mandated by guidelines (HR <60 and SBP <120). Esmolol is an ultra-short-acting beta-blocker often preferred in the acute setting because it can be easily titrated or stopped if the patient decompensates (e.g., due to tamponade or severe aortic regurgitation, though the TTE here makes these less likely). Even if a vasodilator (like nitroprusside) is needed subsequently to reach the BP target, starting the beta-blocker to achieve the HR and BP goals is the correct immediate step.\n*   D. Administer IV morphine: Pain control is important but is secondary to hemodynamic stabilization.\n*   E. Perform transesophageal echocardiography: In a hemodynamically stable (hypertensive) patient, CT angiography is generally preferred over TEE for diagnosis as it is less invasive and allows visualization of the entire aorta. TEE is often reserved for unstable patients or intraoperative use.\n\nTherefore, the most appropriate immediate management step is to initiate anti-impulse therapy with strict adherence to heart rate and blood pressure targets.\n\nThe answer is (C)"}, {"quiz_id": "ABMS20260101_deepseek-v3.2_p05", "question_id": "ABMS20260101_deepseek-v3.2_p05-006", "question": "A 28-year-old primigravida at 36 weeks gestation presents with progressive dyspnea and orthopnea. Echocardiography shows peripartum cardiomyopathy with LVEF 30%. After diuresis with furosemide, she remains symptomatic. Which of the following medications should be avoided until after delivery?", "options": ["Digoxin 0.125 mg daily", "Hydralazine 25 mg three times daily", "Isosorbide dinitrate 20 mg three times daily", "Sacubitril/valsartan 24/26 mg twice daily", "Metoprolol succinate 25 mg daily"], "answer": "D", "answer_index": 3, "explanation": "Sacubitril/valsartan contains an ARB (valsartan) which is contraindicated in pregnancy due to fetal renal toxicity and oligohydramnios risk, particularly in the third trimester. Digoxin, hydralazine, isosorbide dinitrate, and metoprolol are all acceptable in pregnancy for heart failure management. While ACE inhibitors and ARBs are absolutely contraindicated, the other medications listed can be used with appropriate monitoring.", "generator_model": "deepseek-v3.2", "seed": 126, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Obstetrics and Gynecology", "abms_specialty": "Obstetrics and Gynecology", "abms_source": "topics_mapped", "source_label_raw": "obstetrics", "source_quiz_id": "20251205T084024622Z_deepseek-v3.2_seed126", "source_question_id": "20251205T084024622Z_deepseek-v3.2_seed126-007", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/deepseek-v3.2/20251205T084024622Z_deepseek-v3.2_seed126", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251205T084024622Z_deepseek-v3.2_seed126.jsonl", "pred": "D", "model_outputs": "Here is the evaluation of the options provided:\n\n*   A. Digoxin: Digoxin is generally considered safe for use during pregnancy to treat heart failure and arrhythmias. It crosses the placenta but is not teratogenic.\n*   B. Hydralazine: Hydralazine is a vasodilator frequently used in pregnancy to treat hypertension and is safe. In the setting of heart failure during pregnancy, the combination of hydralazine and nitrates is the preferred alternative to ACE inhibitors/ARBs for afterload reduction.\n*   C. Isosorbide dinitrate: Nitrates are generally considered safe in pregnancy and are used in combination with hydralazine for heart failure management when RAAS inhibition is contraindicated.\n*   D. Sacubitril/valsartan: This medication includes valsartan, an angiotensin II receptor blocker (ARB). Drugs acting on the renin-angiotensin-aldosterone system (ACE inhibitors, ARBs, ARNIs) are contraindicated in pregnancy, particularly in the second and third trimesters. They are associated with severe fetal toxicity, including renal failure, oligohydramnios, pulmonary hypoplasia, and calvarial ossification defects. Consequently, this medication must be avoided until after delivery.\n*   E. Metoprolol succinate: Beta-blockers are a cornerstone of therapy for heart failure with reduced ejection fraction. While they cross the placenta and can be associated with fetal growth restriction or neonatal hypoglycemia/bradycardia, the maternal benefit in severe cardiomyopathy typically implies they should be continued or initiated. They are not absolutely contraindicated like ARBs.\n\nThe answer is (D)"}, {"quiz_id": "ABMS20260101_deepseek-v3.2_p05", "question_id": "ABMS20260101_deepseek-v3.2_p05-007", "question": "A 19-year-old male with a history of autism spectrum disorder (level 1) is admitted to the inpatient psychiatry unit after he threatened his parents with a knife. He states that a 'voice from the computer' told him his parents were replaced by impostors. He has no prior psychiatric admissions. He is started on risperidone. Over the next 72 hours, he develops high fever (39.5°C), generalized muscle rigidity, labile blood pressure, and confusion. Creatine kinase is elevated at 5,000 U/L. Which of the following is the most appropriate next step in management?", "options": ["A. Switch risperidone to olanzapine and continue monitoring", "B. Administer intravenous dantrolene", "C. Administer intravenous bromocriptine", "D. Discontinue risperidone immediately and provide supportive care", "E. Add lithium carbonate to treat underlying mood disorder"], "answer": "D", "answer_index": 3, "explanation": "This is neuroleptic malignant syndrome (NMS), a life-threatening reaction to antipsychotics. The immediate and essential step is to discontinue the offending agent (risperidone). Supportive care (cooling, hydration, monitoring) is the cornerstone of management. While dantrolene (B) and bromocriptine (C) have been used as adjuncts in severe cases, they are not first-line and are reserved for refractory cases; their evidence is weak and they carry risks. Switching to another antipsychotic (A) or adding lithium (E) would be dangerous and could worsen NMS.", "generator_model": "deepseek-v3.2", "seed": 134, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Psychiatry", "abms_specialty": "Psychiatry", "abms_source": "target_topic", "source_label_raw": "Psychiatry", "source_quiz_id": "20251225T200227925Z_deepseek-v3.2_seed134", "source_question_id": "20251225T200227925Z_deepseek-v3.2_seed134-007", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/deepseek-v3.2/20251225T200227925Z_deepseek-v3.2_seed134", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251225T200227925Z_deepseek-v3.2_seed134.jsonl", "pred": "D", "model_outputs": "The clinical presentation of high fever (39.5°C), generalized muscle rigidity (\"lead-pipe\" rigidity), labile blood pressure (autonomic instability), altered mental status (confusion), and elevated creatine kinase (CK) shortly after initiating an antipsychotic medication (risperidone) is diagnostic of Neuroleptic Malignant Syndrome (NMS). NMS is a medical emergency.\n\nThe management of NMS follows a hierarchy of interventions:\n1.  Immediate discontinuation of the offending antipsychotic agent. This is the single most important step in management. Continuing the medication will worsen the outcome and increase mortality risk.\n2.  Supportive care: This includes admission to an intensive care unit (ICU), aggressive hydration (to prevent acute kidney injury from rhabdomyolysis), cooling measures for hyperthermia, and management of blood pressure and electrolytes.\n3.  Pharmacologic therapy: Medications such as dantrolene (a direct-acting skeletal muscle relaxant) or bromocriptine (a dopamine agonist) are used as adjunctive therapies. They are typically reserved for moderate-to-severe cases (e.g., extreme hyperthermia, severe rigidity) or those that do not respond to supportive care and withdrawal of the neuroleptic alone.\n\nComparing the options:\n*   A: Switching to another antipsychotic (olanzapine) is contraindicated in the acute phase, as cross-reactivity can occur and worsen the NMS. Re-challenge with antipsychotics should only be considered after a washout period (typically 2 weeks).\n*   B & C: While dantrolene and bromocriptine are treatments for NMS, they are adjunctive. Using them without stopping the causative agent is not proper management. Furthermore, bromocriptine is typically administered orally or via nasogastric tube, not intravenously. Option D encompasses the fundamental and mandatory first steps (stopping the drug and supportive care).\n*   D: Discontinuing risperidone and providing supportive care is the definitive and most appropriate initial step. Most cases of NMS can be managed with these measures alone.\n*   E: Lithium is not a treatment for NMS and can potentially potentiate neurotoxicity.\n\nTherefore, the most appropriate next step is to stop the causative agent and provide supportive care.\n\nThe answer is (D)"}, {"quiz_id": "ABMS20260101_deepseek-v3.2_p05", "question_id": "ABMS20260101_deepseek-v3.2_p05-008", "question": "A 4-month-old previously healthy infant presents with acute onset of irritability, vomiting, and lethargy. Physical examination reveals a bulging anterior fontanelle, retinal hemorrhages, and no focal neurologic deficits. Non-contrast head CT shows bilateral subdural hematomas of different ages. The infant's coagulation studies and metabolic panel are normal. Which of the following additional findings would most strongly support a diagnosis of glutaric aciduria type 1 rather than non-accidental trauma?", "options": ["Metaphyseal corner fractures on skeletal survey", "Elevated serum ammonia level", "Frontotemporal atrophy with widened Sylvian fissures on MRI", "Subarachnoid hemorrhage extending into the posterior fossa", "Elevated urine organic acids showing 3-hydroxyglutaric aciduria"], "answer": "E", "answer_index": 4, "explanation": "While glutaric aciduria type 1 can mimic non-accidental trauma with acute encephalopathy and subdural hematomas, the definitive diagnosis requires demonstration of elevated urine organic acids, specifically 3-hydroxyglutaric aciduria. Frontotemporal atrophy (option C) is a characteristic neuroimaging finding but is not diagnostic. Metaphyseal fractures strongly suggest abuse, while elevated ammonia suggests a different metabolic disorder.", "generator_model": "deepseek-v3.2", "seed": 125, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Neurology", "abms_specialty": "Neurology", "abms_source": "topics_mapped", "source_label_raw": "Neurology", "source_quiz_id": "20251205T084024622Z_deepseek-v3.2_seed125", "source_question_id": "20251205T084024622Z_deepseek-v3.2_seed125-002", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/deepseek-v3.2/20251205T084024622Z_deepseek-v3.2_seed125", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251205T084024622Z_deepseek-v3.2_seed125.jsonl", "pred": "E", "model_outputs": "The clinical presentation of a 4-month-old with acute encephalopathy, subdural hematomas (SDH), and retinal hemorrhages raises high suspicion for Non-Accidental Trauma (NAT) (Abusive Head Trauma). However, Glutaric Aciduria Type 1 (GA1) is a rare but well-known metabolic \"mimic\" of NAT.\n\nBreakdown of the options:\n*   A. Metaphyseal corner fractures on skeletal survey: These are classic metaphyseal lesions (CMLs) and are highly specific for abuse/NAT. Finding these would support NAT, not GA1.\n*   B. Elevated serum ammonia level: While seen in Urea Cycle Disorders and some Organic Acidemias, hyperammonemia is not a primary defining feature of GA1 (which typically presents with ketoacidosis or hypoglycemia, though often less severe systemic abnormalities than other organic acidemias). It does not specifically support GA1 in this differential.\n*   C. Frontotemporal atrophy with widened Sylvian fissures on MRI: Infants with GA1 typically have macrocephaly and a characteristic brain malformation involving hypoplasia of the temporal opercula. This results in wide Sylvian fissures (giving a \"bat-wing\" appearance) and enlarged subarachnoid spaces anterior to the temporal lobes. This anatomic configuration stretches the bridging veins, predisposing these infants to subdural hematomas with minimal or no trauma. While this specific MRI pattern is highly *suggestive* of GA1 and explains the SDH, it is an imaging finding that raises suspicion, rather than the definitive diagnosis.\n*   D. Subarachnoid hemorrhage extending into the posterior fossa: This is a nonspecific finding often seen in trauma and does not specifically point to a metabolic etiology.\n*   E. Elevated urine organic acids showing 3-hydroxyglutaric aciduria: The biochemical hallmark and diagnostic standard for Glutaric Aciduria Type 1 is the detection of elevated glutaric acid (variable) and 3-hydroxyglutaric acid (more reliable, especially in low-excretors) in the urine. Detecting this specific metabolite provides definitive biochemical evidence of the disease.\n\nConclusion:\nWhile the MRI findings (Option C) are characteristic and explain the mechanism of the bleed, the identification of the specific metabolic defect (Option E) is the gold standard for diagnosis. A positive confirmatory lab test provides stronger support for a specific medical diagnosis than suggestive imaging. However, both C and E point to GA1; E is the diagnostic criterion.\n\nThe answer is (E)"}, {"quiz_id": "ABMS20260101_deepseek-v3.2_p05", "question_id": "ABMS20260101_deepseek-v3.2_p05-009", "question": "A 3-year-old child with DiGeorge syndrome (22q11.2 deletion) presents with hypocalcemic seizures. Correction of calcium with intravenous calcium gluconate and calcitriol is initiated. Which of the following immunologic parameters, if present, would be an absolute contraindication to live viral vaccination?", "options": ["CD4+ T cell count <500 cells/μL", "Absent thymic shadow on chest radiograph", "Low but detectable T cell receptor excision circles (TRECs)", "Severely reduced proliferative response to phytohemagglutinin", "Complete absence of CD3+ T cells by flow cytometry"], "answer": "E", "answer_index": 4, "explanation": "Complete absence of CD3+ T cells indicates severe combined immunodeficiency (SCID) phenotype within DiGeorge spectrum, which is an absolute contraindication to live vaccines due to risk of disseminated infection. Reduced proliferative responses (option D) indicate functional impairment but not complete absence. Low TRECs suggest poor thymic output but not necessarily SCID. CD4 count and thymic shadow are not definitive contraindications alone.", "generator_model": "deepseek-v3.2", "seed": 125, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Pediatrics", "abms_specialty": "Pediatrics", "abms_source": "topics_mapped", "source_label_raw": "Pediatrics", "source_quiz_id": "20251205T084024622Z_deepseek-v3.2_seed125", "source_question_id": "20251205T084024622Z_deepseek-v3.2_seed125-008", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/deepseek-v3.2/20251205T084024622Z_deepseek-v3.2_seed125", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251205T084024622Z_deepseek-v3.2_seed125.jsonl", "pred": "A", "model_outputs": "The clinical scenario describes a child with DiGeorge syndrome (22q11.2 deletion). The management of vaccination in these patients depends on the degree of immunodeficiency.\n\n1.  Pathophysiology: DiGeorge syndrome is characterized by thymic hypoplasia or aplasia, resulting in a quantitative defect in T cells (decreased production). Patients are categorized as having \"Partial\" DiGeorge syndrome (the vast majority, who have some thymic function and T cells) or \"Complete\" DiGeorge syndrome (athymia, <1.5% of cases, SCID-like phenotype).\n\n2.  Vaccination Guidelines: Live viral vaccines (such as MMR and Varicella) are generally contraindicated in patients with severe cellular immunodeficiency due to the risk of uncontrolled viral replication.\n    *   According to the American Academy of Pediatrics (Red Book) and ACIP guidelines, the decision to vaccinate a child with DiGeorge syndrome with live viral vaccines is based on age-specific CD4+ T cell counts and evidence of immune function (mitogen response).\n    *   For a child aged 1 to 5 years, severe immunosuppression is defined as a CD4+ T cell count < 500 cells/μL (or <15%).\n    *   Live vaccines can be administered to patients with DiGeorge syndrome if they do *not* have severe immunosuppression (i.e., if CD4+ count is ≥ 500 cells/μL for this age group) and have adequate T cell function.\n\n3.  Evaluating the Options:\n    *   A. CD4+ T cell count <500 cells/μL: This is the established threshold for severe suppression in children aged 1–5 years. If the count is below this level, live viral vaccination is contraindicated. This covers both \"Complete\" DiGeorge (count ~0) and \"Severe Partial\" DiGeorge cases. This is the correct parameter and cutoff.\n    *   B. Absent thymic shadow: This is a radiological finding common in DiGeorge syndrome but does not correlate perfectly with immune function. Many patients with no visible thymic shadow still have sufficient T cell numbers (from microscopic or ectopic thymic tissue) to be vaccinated safely.\n    *   C. Low but detectable TRECs: T cell receptor excision circles (TRECs) mark recent thymic emigrants. \"nondetectable\" TRECs would suggest complete DGS/SCID. \"Detectable\" TRECs indicate some thymic output (Partial DGS), which usually allows for vaccination provided counts are adequate.\n    *   D. Severely reduced proliferative response to PHA: While a severely reduced mitogen response is a contraindication, in DiGeorge syndrome, the primary defect is usually quantitative (low numbers) rather than qualitative (dysfunctional cells). The T cells present usually function normally. Therefore, the absolute CD4 count is the primary and most standard screening metric used to determine vaccine eligibility in this condition.\n    *   E. Complete absence of CD3+ T cells: This describes \"Complete\" DiGeorge syndrome. While this is an absolute contraindication, it is not the *only* contraindication. A child with low but present T cells (e.g., 200 cells/μL) also cannot receive the vaccine. Therefore, Option A is the superior answer because it encompasses the full range of contraindications (Severe Partial and Complete phenotypes) based on the safety guidelines.\n\nThe answer is (A)"}, {"quiz_id": "ABMS20260101_deepseek-v3.2_p05", "question_id": "ABMS20260101_deepseek-v3.2_p05-010", "question": "A neonate born at 32 weeks gestation develops necrotizing enterocolitis (NEC) on day 10 of life. During laparotomy, approximately 40% of the small bowel appears necrotic. Which of the following intraoperative findings would mandate creation of a high jejunostomy rather than primary anastomosis?", "options": ["Involvement of the ileocecal valve", "Necrosis extending to within 5 cm of the ligament of Treitz", "Presence of pneumatosis intestinalis in the remaining bowel", "Concurrent isolated perforation of the gastric fundus", "Development of abdominal compartment syndrome during surgery"], "answer": "B", "answer_index": 1, "explanation": "Necrosis extending to within 5 cm of the ligament of Treitz indicates near-total small bowel loss, requiring high jejunostomy to preserve the maximal possible length of viable bowel for future adaptation and prevent anastomotic leakage in compromised tissue. Ileocecal valve involvement is important for absorption but doesn't dictate anastomosis vs ostomy. Pneumatosis may be present in non-necrotic bowel. Gastric perforation is managed separately. Abdominal compartment syndrome may require temporary closure but not necessarily jejunostomy.", "generator_model": "deepseek-v3.2", "seed": 125, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Pediatrics", "abms_specialty": "Pediatrics", "abms_source": "topics_mapped", "source_label_raw": "Pediatrics", "source_quiz_id": "20251205T084024622Z_deepseek-v3.2_seed125", "source_question_id": "20251205T084024622Z_deepseek-v3.2_seed125-010", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/deepseek-v3.2/20251205T084024622Z_deepseek-v3.2_seed125", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251205T084024622Z_deepseek-v3.2_seed125.jsonl", "pred": "C", "model_outputs": "In the surgical management of necrotizing enterocolitis (NEC), the decision between performing a primary anastomosis versus creating an enterostomy (stoma) depends on patient stability and the condition of the remaining bowel.\n\n1.  Analyzation of Option C (Presence of pneumatosis intestinalis in the remaining bowel): The most critical factor for a successful primary anastomosis is the viability and quality of the bowel ends being connected. Pneumatosis intestinalis indicates active disease, inflammation, and ischemia within the bowel wall. Anastomosing bowel segments that exhibit pneumatosis carries a prohibitively high risk of anastomotic leak, dehiscence, and stricture formation. Therefore, the presence of pneumatosis in the \"remaining\" (non-necrotic) bowel is an absolute contraindication to primary anastomosis. It mandates the creation of a diverting stoma (enterostomy) proximal to the diseased bowel to allow the distal segments to heal and to prevent leakage. If the disease necessitates resection or diversion high in the GI tract, a high jejunostomy results.\n\n2.  Analyzation of Option B (Necrosis extending to within 5 cm of the ligament of Treitz): If necrosis extends very proximally, leaving only a short segment of jejunum distal to the ligament of Treitz, the creation of a stoma (high jejunostomy) is fraught with severe complications, such as difficulty in appliance fitting, skin breakdown, and unmanageable fluid/electrolyte losses. In these cases, if the distal bowel is viable, surgeons often *prefer* a primary anastomosis (or procedures like the Santulli enterostomy) to preserve bowel length and absorptive capacity, rather than creating a stoma that is difficult to manage. Thus, this finding argues *against* a stoma if an anastomosis is technically feasible, or at least does not \"mandate\" it over anastomosis in the same way tissue compromise does.\n\n3.  Analyzation of Option A (Involvement of the ileocecal valve): While resection of the ileocecal valve has long-term nutritional implications, it does not preclude primary anastomosis (e.g., ileocolic anastomosis) if the ends are healthy and the patient is stable.\n\n4.  Analyzation of Option E (Abdominal compartment syndrome): If ACS develops, the abdomen is typically left open (laparostomy/damage control). In this setting, the bowel ends are usually stapled off or a \"clip and drop\" technique is used. While an anastomosis is avoided, a matured high jejunostomy is also typically not created during the acute damage control phase; the priority is decompression.\n\n5.  Analyzation of Option D (Concurrent gastric perforation): This is a comorbid condition. The stomach is repaired. The management of the small bowel (anastomosis vs. stoma) still relies on the condition of the small bowel itself.\n\nTherefore, the finding that specifically renders primary anastomosis unsafe and mandates diversion is the poor quality of the remaining tissue.\n\nThe answer is (C)"}]